Minerva Neurosciences, Inc. — Director's Dealing 2016

Dec 20, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2016-12-16

Reporting Person: Davidson Michael (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$12.35	2026-08-31	Common Stock (30000)		Direct

Footnotes

F1: The shares underlying the option shall vest and become exercisable as to 25% on September 1, 2017; the balance of the shares underlying the option shall vest and become exercisable in 12 successive equal quarterly installments, in each case so long as the Reporting Person provides continuous service to the Issuer on each such date.